| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/28/2006 | WO2006051531A3 Radioimaging |
| 09/28/2006 | WO2005034732A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/28/2006 | US20060218655 Used for identifying a drug capable of treating a B cell lymphoma, capable of depleting or killing cells expressing human CD20, or capable of inducing an Fc-mediated effector cell response; testing the safety or efficacy of anti-human CD20 therapy |
| 09/28/2006 | US20060217292 Vitronectin receptor antagonist compounds and their use in the preparation of diopharmaceuticals |
| 09/28/2006 | US20060216310 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 09/28/2006 | US20060216239 nanoparticle having a core comprising a magnetic material and surface to which are covalently coupled a plurality of silane moieties |
| 09/28/2006 | US20060216238 Compositions and methods for targeting or imaging a tissue in a vertebrate subject |
| 09/28/2006 | CA2602946A1 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | CA2570563A1 Method for screening agents against human prostate disease |
| 09/27/2006 | EP1704864A2 Process for producing an injectable pharmaceutical preparation |
| 09/27/2006 | EP1704157A1 Metal complexes having vitamin b12 as a ligand |
| 09/27/2006 | EP1482986B1 Method for determining effect of a clostridial toxin upon a muscle |
| 09/27/2006 | EP0759786B1 Somatostatin binding peptide-metal chelate conjugates |
| 09/27/2006 | CN1838978A Gastrointestinal methods and apparatus for use in treating disorders |
| 09/26/2006 | US7114009 Encapsulating Fibre Channel signals for transmission over non-Fibre Channel networks |
| 09/26/2006 | US7112453 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 09/26/2006 | US7112412 Binding to prostate specific membrane antigen (PSMA) with a radioactive monoclonal antibody or Fab fragments; detecting and kill the cancer cells; bioassay; radiotherapy |
| 09/26/2006 | US7112338 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 09/26/2006 | US7112319 Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using microelectrodes with microvoltammetry |
| 09/26/2006 | US7112318 Phosphonium or quaternary ammonium salts labeled with 11C, 18F,76Br, or 123I; for positron emission tomography; capable of measuring mitochondrial surface potential; localize into dysfunctional mitochondria |
| 09/26/2006 | US7112317 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker. |
| 09/26/2006 | CA2243316C Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis |
| 09/21/2006 | WO2006099516A2 Methods for magnetic resonance imaging |
| 09/21/2006 | WO2006099037A2 A sporadic tumor mouse model for drug discovery |
| 09/21/2006 | WO2006099019A2 Methods and composition related to in vivo imaging of gene expression |
| 09/21/2006 | WO2006085908A9 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
| 09/21/2006 | WO2006045037A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 09/21/2006 | US20060211941 Arrangement and method for the spatially resolved determination of state variables in an examination area |
| 09/21/2006 | US20060211938 Method for spatially resolved determination of magnetic particle distribution in an area of examination |
| 09/21/2006 | US20060211671 agonists used for prevention of obesity in mammals; receptor binding assay; drug screening |
| 09/21/2006 | US20060211038 Methods for detecting vasculopathies and tumors |
| 09/21/2006 | US20060210987 Method for the spatially resolved determination of physcial, chemical and/or biological properties or state variables |
| 09/21/2006 | US20060210986 Method of determining state variables and changes in state variables |
| 09/21/2006 | US20060210710 Processes for manufacturing polymeric microspheres |
| 09/21/2006 | US20060210480 Treatment of reduction of dysphagia |
| 09/21/2006 | US20060210479 Targeting chelants and chelates |
| 09/21/2006 | US20060210478 Steady state perfusion methods |
| 09/21/2006 | US20060210477 Therapeutic agent for cancer |
| 09/21/2006 | US20060210476 Metabonomics homogeneity analysis |
| 09/21/2006 | US20060210473 VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment |
| 09/21/2006 | DE102005011579A1 Affinity marker for molecules has a hemagglutinin epitope (HA) domain with HA tag(s) and a streptavidin (Strep) domain with Strep tag(s) |
| 09/21/2006 | CA2601243A1 Methods and composition related to in vivo imaging of gene expression |
| 09/21/2006 | CA2601069A1 Contrast agents for magnetic resonance imaging |
| 09/20/2006 | EP1702914A1 Radio-opaque polymeric biomaterials |
| 09/20/2006 | EP1702628A2 Contrast agents for medical devices |
| 09/20/2006 | EP1701978A2 Use of t-cadherin as a target |
| 09/20/2006 | EP1701745A1 Gas-filled microvesicle assembly for contrast imaging |
| 09/20/2006 | EP1701611A1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar |
| 09/20/2006 | CN1835955A 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 09/20/2006 | CN1835913A Propionic acid derivatives useful in the treatment of lipid disorders |
| 09/20/2006 | CN1835769A KIM-1 antagonists and use to modulate immune system |
| 09/20/2006 | CN1833727A Use of Arab gum in setting up animal's model and lowering blood cholestenone |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/19/2006 | US7110808 Method of optimizing radiosurgery and radiotherapy with metalloporphyrins |
| 09/19/2006 | US7110806 Method for imaging an artery using a magnetic resonance contrast agent |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109188 motexafin gadolinium or lutetium for injection in sealed glass vial purged of oxygen; radiation sensitizer acts to catalyze the oxidation of NAD(P)H, ascorbate and other reducing agents |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7108858 Immunological protein |
| 09/19/2006 | US7108846 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 09/19/2006 | US7108845 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/14/2006 | WO2006096207A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/14/2006 | WO2006095936A1 Nanohybrid particles for diagnosis and treatment of tumor |
| 09/14/2006 | WO2006095905A1 Tumor marker and diagnostic kit using the same |
| 09/14/2006 | WO2006095771A1 Complex compound and mri probe made of same |
| 09/14/2006 | WO2006095745A1 Diethylenetriaminepentaacetic acid derivative, gadolinium- diethylenetriaminepentaacetic acid derivative complex, mri contrast medium, and contrast medium specific to hypervascular tumor |
| 09/14/2006 | WO2006095636A1 Novel compound selectively activated at target site and utilization of the same |
| 09/14/2006 | WO2005100612A3 Bacteriophage imaging of inflammation |
| 09/14/2006 | WO2005084710B1 Nanocell drug delivery system |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | US20060205967 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 09/14/2006 | US20060205656 P-superfamily conopeptides |
| 09/14/2006 | US20060204445 Cell scaffold matrices with image contrast agents |
| 09/14/2006 | US20060204444 Protein cages for the delivery of medical imaging and therapeutic agents |
| 09/14/2006 | US20060204443 Methods for tumor treatment using dendrimer conjugates |
| 09/14/2006 | US20060204442 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 09/14/2006 | US20060204441 Cell scaffold matrices with incorporated therapeutic agents |
| 09/14/2006 | US20060204440 Radio-opaque polymeric biomaterials |
| 09/14/2006 | US20060204439 Administering isotope labeled water to tissue; measurement, calibration |
| 09/14/2006 | US20060204438 Water soluble iron oxide nanoparticles and a method of its preparation |
| 09/14/2006 | US20060204437 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 09/14/2006 | DE102005024626B3 Catheter for insertion and creation of a stent within a body conduit has a filling space that is filled with plastic at the point at which the stent is to be created and then the plastic hardened prior to removal of the catheter |
| 09/14/2006 | CA2575730A1 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/13/2006 | EP1700118A1 Retinal toxicity screening methods |
| 09/13/2006 | EP1699917A2 Stem cell targeting using magnetic particles |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699493A1 Polymeric marker with high radiopacity for use in medical devices |
| 09/13/2006 | EP1506027B1 Cell delivery fluid for prevention of cell settling in delivery system |
| 09/13/2006 | EP1183050B1 Method for producing an injectable medicament preparation |
| 09/13/2006 | CN1833020A Pro104 antibody compositions and methods of use |
| 09/12/2006 | US7105339 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 09/12/2006 | US7105312 Ca2+/calmodulin-dependent protein kinase IV |
| 09/12/2006 | US7105292 ultraviolet radiation-regulated molecules as markers for ultraviolet radiation exposure; expression of nucleic acid molecules are repressed or induced in response to ultraviolet radiation exposure |
| 09/12/2006 | US7105229 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 09/12/2006 | US7105170 comprises in vitro granuloma model containing fibroblasts for drug screening vaccines; kits |
| 09/12/2006 | US7105160 Antibody-serum protein hybrids |
| 09/12/2006 | US7105151 Oxygen delivery agents and uses for the same |
| 09/12/2006 | US7105150 Contacting neural cells with a reagent that recognizes a determinant on a cell surface marker recognized by monoclonal antibody AC133 or 5E12; selecting cells where there is contact between reagent and determinant |
| 09/12/2006 | CA2215069C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |